GEOMX

Serial Number 87982200
Registration 5945133
700

Registration Progress

Application Filed
May 9, 2018
Under Examination
Feb 5, 2019
Approved for Publication
Dec 11, 2018
Published for Opposition
Dec 11, 2018
Registered
Dec 24, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20191224) (Grace Period Filing)
Due: Jun 24, 2026 Grace Period - 177 days
Original deadline was Dec 24, 2025 (overdue)

Trademark Image

GEOMX

Basic Information

Serial Number
87982200
Registration Number
5945133
Filing Date
May 9, 2018
Registration Date
December 24, 2019
Published for Opposition
December 11, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2019
Registration
Registered
Classes
001 009 010 042

Rights Holder

BRUKER SPATIAL BIOLOGY, INC.

03
Address
40 MANNING ROAD
BILLERICA, MA 01821

Ownership History

NanoString Technologies, Inc.

Original Applicant
03
Seattle, WA

NanoString Technologies, Inc.

Owner at Publication
03
Seattle, WA

NanoString Technologies, Inc.

Original Registrant
03
Seattle, WA

BRUKER SPATIAL BIOLOGY, INC.

New Owner After Registration #1
03
BILLERICA, MA

Legal Representation

Attorney
Alyssa Worsham

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191224)
Due Date
December 24, 2025
Grace Period Ends
June 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Dec 11, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 24, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 4, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 24, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 21, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 20, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 28, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 23, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 28, 2019 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 23, 2019 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 25, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 23, 2019 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 23, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 5, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 2, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 15, 2019 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 15, 2019 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Aug 15, 2019 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 15, 2019 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Feb 5, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 11, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 2, 2018 ALIE A ASSIGNED TO LIE Loading...
Oct 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 15, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 31, 2018 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Aug 31, 2018 GPRA F PRIORITY ACTION E-MAILED Loading...
Aug 31, 2018 CPRA R PRIORITY ACTION WRITTEN Loading...
Aug 30, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 18, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
reagents and instruments for scientific, research or non-medical or veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific or research use in the fields of cancer, neurology and infectious disease; reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for scientific, research or non-medical or veterinary diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientific, research or non-medical or veterinary diagnostic use in the fields of cancer, neurology and infectious disease; reagents for immuno-histochemistry detection and in situ-hybridization detection for scientific, research or non-medical or veterinary diagnostic use; test kits for scientific, research or non-medical or veterinary diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; test kits comprising reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical or medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers
First Use Anywhere: Sep 3, 2019
First Use in Commerce: Sep 3, 2019
Class 009
automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for detection and analysis of biomolecules for scientific use; automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for scientific research, namely, for detecting, collecting and processing optical signals and images, into data for use in the analysis of biomolecules in connection with scientific or medical research; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for digitizing images of biological tissue for use in connection with pathology; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for capturing digital images of microscope slides of biological tissue, storage of digitized microscope slide images in a data storage area, and display of digitized microscope slide images; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems comprised of computer hardware and software for detection and analysis of, pathology, gene expression, RNA transcription, RNA translation and nucleic acid sequencing; computer hardware and software to enable pathologists to diagnose disease; computer hardware and software for the electronic scanning of clinical pathology slides; computer hardware and software for pathologists to render and report diagnoses and results of scientific research; computer hardware and software for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription and microRNA expression profiling and nucleic acid sequencing; computer hardware and software for digitizing, processing and storing images of biological tissues and cells; computer hardware and software for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining and visualization apparatus; computer hardware and software for identifying and diagnosing cancer and other diseases and processing digital images; computer hardware and software for viewing, analyzing, managing, reporting, and archiving digital images; laboratory equipment for sample preparation, mixing, hybridization, incubation, washing, location and imaging, namely, robotic equipment, fluid mixers, pumps, valves, and containers, reagent holders, sample containers and microfluidic devices, optical devices, scanning microscopes, fluorescent microscopes, digital micromirror devices, electromagnetic sensors and replacement parts therefor in the fields of scientific research; computer systems, namely, software and data files to acquire, analyze, manage and report biological information
First Use Anywhere: Sep 3, 2019
First Use in Commerce: Sep 3, 2019
Class 010
clinical and medical diagnostic instruments, namely, histopathology instruments and nucleic acid sequencers; clinical and medical diagnostic instruments for analysis of tissue and/or cell based samples, all for medical purposes; clinical and medical diagnostic instruments for performing immunohistochemistry and in situ-hybridization staining reactions, histological and pathological staining and image processing and analysis; histopathology instruments for clinical purposes; clinical and medical diagnostic instruments for immunohistochemistry and in situ-hybridization analyses; clinical and medical diagnostic instruments for the electronic scanning of clinical pathology slides, processing and storing images of biological tissues and cells and digitizing, processing and storing images of biological tissues and cells
First Use Anywhere: Sep 3, 2019
First Use in Commerce: Sep 3, 2019
Class 042
research and product development services for others in the field of biotechnology; medical and scientific research services for others in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research services for others in the field of infectious disease; medical and scientific research services for others in the field of neurology; medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological samples, medical samples, and cell samples; providing laboratory research services for others in the field of gene expression and genetic data mining; research and development services for others for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes
First Use Anywhere: Apr 1, 2019
First Use in Commerce: Apr 1, 2019

Classification

International Classes
001 009 010 042